antihemophilic factor

(redirected from ReFacto)
Also found in: Dictionary, Thesaurus, Medical.

antihemophilic factor

[¦an·tē‚hē·mə′fil·ik ‚fak·tər]
(biochemistry)
A soluble protein clotting factor in mammalian blood. Also known as factor VIII; thromboplastinogen.
References in periodicals archive ?
Sobi will continue to be the global supplier of the drug substance for ReFacto AF/XYNTHA, which is produced in Sobi's plant in Stockholm.
Total revenues of ReFacto for the quarter were SEK74m in CER, reportedly lower than the corresponding period of the prior year as a result of annual phasing of manufacturing shipments to Pfizer and a lower royalty rate.
The company, the nation's seventhlargest pharmaceutical manufacturer, is awaiting regulatory approval of several other medicines: Rapamune, an organ transplant drug; ReFacto, a hemophilia treatment; Protonix, an ulcer drug; and a vaccine that the company says could be used to fight seven common strains of pneumococcal bacteria.
The rise in revenue from the two products will offset the expected decline in revenue from the company's hemophilia A drug ReFacto, Biovitrum said.